References

  1. Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010; 115(2): 168-186.
  2. Cheng Y, Wong RSM, Soo YOY, et al. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. N Engl J Med. 2003; 349(9): 831-836.
  3. Mazzucconi MG, Fazi P, Bernasconi S, et al. Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience. Blood. 2007; 109(4): 1401-1407.
  4. Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019; 3(22): 3780-3817.

Additional TBP resources:

PlatformTitleComments
Case study34 year-old man with incidental finding of thrombocytopeniaThis case explores first line therapy in a patient presenting with ITP
InfographicInfographic on ITPIncludes diagnostic, pathophysiologic, therapeutic and historical considerations
Prev
 1 / 00 
Next